Home/ Supplements/ Melatonin/ ZzzQuil Pure Zzzs Blackberry Vanilla Fla...

ZzzQuil Pure Zzzs Blackberry Vanilla Flavored

product on market Gummy or Jelly Vicks Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product contains melatonin and a botanical blend intended to support sleep onset. Research provides strong evidence for melatonin's effectiveness in reducing sleep latency, while evidence for the accompanying triple action blend is more limited. The formulation maintains a high safety profile for short-term use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for ZzzQuil Pure Zzzs Blackberry Vanilla Flavored
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Gummy(ies)
Serving Size
30
Servings
Other Combinations
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
25 Calorie(s)
Total Carbohydrates
6 Gram(s) (2% DV)
Sodium
15 mg (1% DV)
6 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)
Pure Zzzs Triple Action Blend
230 mmg

Other Ingredients

Corn Syrup Water Sugar Maltodextrin Coconut Oil, Hydrogenated Pectin Natural Flavors Sodium Potassium Tartrate Citric Acid Soy Lecithin Sodium Citrate Malic Acid Sodium Polyphosphate Red 40 Blue 1
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Warnings & Precautions

Contains: Soy, Tree Nuts (Coconut)

Formulation Notes

3x Melatonin Melatonin + Ashwagandha

Triple action Supports sleep, calm mood & antioxidant action

Metadata

Product Details

DSLD Entry Date2024-12-21
Product TypeOther Combinations
FormGummy or Jelly
BrandVicks
DSLD ID322794
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.